*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

agree banjo and look just how many tests are carried out every year. Massive market in US as soon as we get FDA.

yep and a pretty big market in Europe too!

Update from Hospitalar:

20.06.08

HOSPITALAR 2008 sets a new record in business deals

"HOSPITALAR 2008, held from June 10th to 13th in S Paulo (Brazil), has closed with a result of R$ 4.4 billion (US$ 2.7 billion) in sales and orders, around 78,000 professional visits, from 72 countries, and the expectation of a 20% growth for the next year."

"The fair is traditionally responsible for 25% of the annual sales turnover of the medical-hospital industry. The companies program their launches for this date and the buyers program their purchases for the period of HOSPITALAR or for right after the fair, highlights Dr. Waleska Santos. A survey carried out with the exhibitors indicates that the business deals made and stimulated during the fair sum up to R$ 4.4 billion, about 10% more than the 2007 edition."

http://www.hospitalar.com/ingles/

Not sure how old this is but can't remember seeing it before.Posted just out of interest with Mark Emberton involved (MDW's Non-Executive Director):


http://www.users.totalise.co.uk/~rifat/prostab/pros.html

The next event that MDW will be participating in is The British Association of Urological Surgeons (BAUS) which starts on Monday 23rd to Friday 27th June 2008 at Manchester Central.

"On Thursday the Section of Oncology has plenary sessions on non muscle invasive bladder cancer and NICE Prostate Cancer Guidance."

http://www.baus.org.uk/baus_annual_meeting_2008_.phtml

For anyone interested NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.

http://www.nice.org.uk/

Improving Outcomes in Urological Cancers (if you have a spare 5 minutes),this is what will be discussed at BAUS:

http://www.nice.org.uk/nicemedia/pdf/Urological_Research_Evidence.pdf

There will be more to follow but too busy watching the footy :-)

lol 1-1 and penalties,sorry off topic

Article nicked from over on the 'Dark Side' with MDW's PSAwatch maybe having an influence in the formation of the MDW/Device Technologies 5 year strategic relationship:

http://www.nzdoctor.co.nz/news?article=57538ac2-1560-402f-949e-bcb5f76cf302

http://moneyam.uk-wire.com/cgi-bin/articles/200711280700336008I.html

http://www.device.co.nz/preview.php?link1=27&which=1

Will have a good look at this later,some interesting recent charts and figures:

http://www.cancer.org/downloads/STT/Cancer_Statistics_2008.ppt

I missed this event:

The American Society of Colon and Rectal Surgeons

June 7-11,2008 Hynes Convention Center & Sheraton Boston Hotel Boston,MA

Mediwatch, PLC Booth 421

1501 Northpoint Parkway, Ste 103
West Palm Beach FL 33407

Phone: (888) 471-2611
FAX: (866) 871-8939

Website: www.mediwatch.com

Mediwatch offers the best in Pelvic Floor diagnostic
products. We provide Urodynamics, Ultrasound, Anorectal
Manometry and Pudendal Nerve testing devices, which are
complimented with complete training and long-term
support. Our display includes the Sensic Urodynamics
system, Encompas Total Pelvic Floor diagnostic system,
Portascan Ultrasound and Multiscan Ultrasound systems.

http://www.fascrs.org/gedownload!/ASCRS_FinalProgram08_5-8LR.pdf?item_id=936004&version_id=936005


Edit-There may be more info.relating to MDW within the above doc. but what is very interesting both in general and within the 'abstracts' is the input from Australia/New Zealand!

'State of the art to make your practice start!' sorry :-)

(Ed-you should be!)

Mediwatch plc

('Mediwatch' or 'the Company')

Mediwatch to distribute ground-breaking molecular test for prostate cancer


Mediwatch, (AIM: MDW) has acquired extensive rights to distribute a new ground-breaking molecular test which could have a major impact upon the detection of prostate cancer.

Mediwatch has signed an agreement with Bostwick Laboratories Inc. a general reference laboratory headquartered in Richmond, Virginia, USA) granting it sole rights to sell the nucleic acid amplification based PCA3PlusTM test worldwide, with the exception of Canada and the USA.

http://moneyam.uk-wire.com/cgi-bin/articles/200806250700074597X.html

To clarify regarding todays news and only in my opinion:

1. The PCA3Plus test is a new gene test for the PCA3(DD3) gene where a PCA3 score is determined.

2. MDW have the global rights excluding USA and Canada for Bostwick Laboratories own branded test for PCA3 which is called PCA3Plus,there are other companies that do the PCA3 test under there own brand name.

3. The PCA3 test has no FDA approvals at the present time so is not available in the USA.

4. The PCA3 test does in NO way replace the PSA test and DRE examination but is being widely thought of as an addition and a major step forward in preventing unnecessary biopsies.

5. From what I can gather the PCA3 test is a lot more expensive than a PSA test and requires sending to a lab so time wise we are looking at days for a result.

Todays announcement is very positive but not short term revenue generating wise which explains the lack of interest.

MDW are fast becoming THE major player within their sector and todays news is proof of this fact!

Six monthly revenues,

to APR '06 - 979k
to OCT '06 - 830k
to APR '07 - 1.829m
to OCT '07 - 3.855m

MDW's interims are due next month and they will speak volumes in the direction they are heading,of course this is in my opinion but this is a well studied opinion!

dyor,ect ect ect

banjomick,
point 3, the test is available in the US (I should imagine it is their biggest market). FDA approval allows anyone to run the test and the Company to market the test, however if the test is performed in a CLIA approved laboratory it is allowed.

Read this link from the Gen-Probe especially the bit at the bottom ,

http://www.pca3.org/pro/labs

As for short term revenue generating I think you may be wrong, Mediwatch would not be issuing an RNS unless this was a significant deal (they are very shy) and they point out it will take effect 'immediately', now most of the other deals T-Doc etc took quite a while before they became effective. If this starts immediately and a test has been in the European market for some years now, then this could provide useful revenue straight away.

Afternoon Minder,
Yes,I know the PCA3 test can be performed at a few US labs but tests cannot be performed at a local level using Bostwick Laboratories PCA3Plus PCA3 test until the PCA3 test has gained FDA approvals.Of the top of my head the USA accounts or used to for about 2/3 of global PSA testing so a major market to get into for both PSA and PCA3 testing.

I may be wrong regarding short term revenue and I hope I am! Yes,the PCA3 test has been available in the EU for about 2 years.

banjomick,
Quite correct about the test, but I am not sure you realise what is needed to perform the PCA3 test. It can only be performed in those large labs that could house the Gen-probe equipment. It is not a test like PSAwatch with a small reader and desktop operating, the PCA3 molecular test requires many complex processes, expensive capital equipment and skilled personnel in a laboratory environment. That is why they are all sent to central labs to have the samples processed, if this is the case then they do not really need to get FDA approval.
The only way these tests could ever be performed at local level is if the platforms can be developed for local level. Gen-Probe is developing its Panther platform for medium and small size hospitals and labs, at the moment it's Tigris platform weighs over half a tonne and needs a very large room to house it and it's peripheral devices

Evening Minder,
I've had a lot on since the PCA3Plus announcement and haven't found the time to to re-look into PCA3 testing,so apologies and cheers for posting.

I read this bit and assumed maybe wrongly that it meant the labs in America were only allowed to carry out research regarding the PSA3 test:

"This test is now becoming routinely available in European countries like Belgium, France, Germany, The Netherlands and the United Kingdom, where different laboratories are certified to perform this test. No PCA3 test has been cleared or approved by the U.S. Food and Drug Administration (FDA). However, several laboratories in the U.S. are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing."

http://www.pca3.org/public

As far as I'm aware the CLIA is basically a code of practice where a lab is closely monitored and assessed.

I have heard of the 'Panther' platform though but I need to do a lot more research over the weekend regarding PCA3,just to clarify in my own mind.

Becoming a little clearer:

"In December 2005, Gen-Probes PCA3 analyte specific reagents were made available to selected laboratories in the U.S. and, in Spring 2006, AmeriPath, in conjunction with Molecular Profiling Institute, and Bostwick Laboratories officially launched their versions of a PCA3-based test using reagents manufactured by Gen-Probe. Other laboratories are being added.

At the end of 2006, Gen-Probe also completed the first phase of the European launch of its CE-marked PROGENSA PCA3 for prostate cancer in six laboratory sites across Europe. Additional laboratories will be distributing the test in subsequent launches over the coming months."

U.S. laboratories
The PCA3 test is not approved for marketing in the U.S. The following laboratories have validated and offer a PCA3-based test using specific reagents manufactured by Gen-Probe.

Ameripath / www.ameripath.com, in conjunction with the Molecular Profiling Institute / www.molecularprofiling.com and Specialty Laboratories / www.specialtylabs.com
Bostwick Laboratories / www.bostwicklaboratories.com
Laboratory Corporation of America / www.labcorp.com
Molecular Oncology Diagnostics Lab / www.molecularoncology.net

Canadian laboratories
The following laboratories offer Gen-Probe's PCA3 test.

MiClub / www.mediclub.ca
Warnex / www.warnex.ca

European laboratories
The following laboratories offer the CE-marked Gen-Probes PROGENSA PCA3 test.

The Doctors Laboratory (London, UK) / www.tdlpathology.com
Labor Limbach (Heidelberg, Germany) / www.labor-limbach.de
Laboratoire LCL (Seine, France) / www.lablcl.com
Laboratoire de Technologies Molulaires Appliqus de lUniversitCatholique de Louvain / www.ltma.be
Medi-Lab (Manchester, UK) / www.medi-lab.co.uk
BARC Global Central Lab (Ghent, Belgium) / www.barclab.com
Biomnis (Ivry/Seine, France) / www.biomnis.com
Gene-Predictis (Granges-Paccot, Switzerland) / www.genepredictis.com
Hadassah and Hebrew University Medical Center (Jerusalem, Israel) / www.hadassah.org.il
Hospices Civils de Lyon (Lyon, France) / www.chu-lyon.fr
IMCL - Krankenhaus der Elisabethinen (Linz, Austria) / www.elisabethinen.or.at
Medix Laboratories (Espoo, Finland) / www.medix.fi
NovioGendix (Nijmegen, the Netherlands) / www.noviogendix.nl
Medizinische Klinik Heidelberg (Heidelberg, Germany)

http://www.diagnocure.com/en/products-projects/prostate-cancer/market-availability.php

Got it now-lol

The PCA3 test developed by Gen-Probe was I assume bought by a few USA labs with Bostwick Laboratories being one who then have the right to rename the PCA3 test to make it their own branded lab based test ie PCA3Plus which MDW have the global rights for except USA/Canada which I assume is covered by Bostwick Laboratories themselves.

Gen-Probe is 'PROGENSA PCA3'
Bostwick Laboratories is 'PCA3Plus'
AmeriPath, Inc is 'PCA3 ProfileR'

I wonder if we will see a close working relationship with Bostwick Laboratories in the future for other tests?

MDW are growing into a pretty big company with their gold seal products offering high accuracy at a reasonable cost along with a major global distribution network that labs having gained the relevant approvals for new tests will I'm sure be looking at MDW with great interest to increase their profit margins!

I will have to post info.on what will be MDW's competition to build up a picture on the PCA3 test,I don't have a problem with this as MDW are not about one particular test.

Medi-Lab Mon 10th Mar, 2008

"Currently, Medi-Lab is the only UK accredited laboratory that is ready to provide the Urine PCA3 service directly (by in-house testing) and is co-operating with PCT's and PBC's that are interested in conducting pilot studies to investigate the potential savings that could be made by using the urine PCA3 test as an aid in the diagnosis and or surveillance of prostate cancer along with or in place of some prostate biopsies.

The reason that Medi-Lab is in this unique position is that they have been using the Genprobe NAAT specialised equipment for the Aptima Chlamydia and Gonorrhoea tests for several years and the urine PCA3 test has been developed and validated exclusively on this equipment.

Therefore prior to the launch of the PCA3 test in Europe in November 2007, Genprobe selected Medi-Lab as their ideal testing facility for the UK.

Medi-Lab's Laboratory Manager, Paul Hayward, has subsequently undertaken and successfully completed a stringent training programme provided by Genprobe in Brussels and is in fact the only UK Chartered Scientist that is qualified and experienced to run the PCA3 test and to train other Medi-Lab Scientists in this specialised procedure.

The number of requests for the Urine PCA3 is steadily growing and so far have been exclusively from the private sector.

Hopefully, NHS patients with the prostate dilemma will soon be able to benefit from this cutting edge technology."

http://www.medi-lab.net/newsdetail.php?id=24

Regarding Bostwick Laboratories PCA3 test the 'PCA3Plus',it sounds like MDW will have to have specialists within a lab based situation to carry out the test,this training could be carried out at Bostwick's UK based lab?

Then again if you read the announcement:

"Mediwatch, (AIM: MDW) has acquired extensive rights to distribute a new ground-breaking molecular test which could have a major impact upon the detection of prostate cancer."

Does this imply that MDW will just offer this test via their website and global sales teams with samples being sent to labs that Bostwick Laboratories are going to build or have interests in outside of America? I know they only have their main labs within the USA and one in the UK.